Cargando…

Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community

Detalles Bibliográficos
Autores principales:	Ruopp, Marcus D., Strymish, Judith, Dryjowicz-Burek, Jonathan, Creedon, Katie, Gupta, Kalpana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826028/ https://www.ncbi.nlm.nih.gov/pubmed/33515497 http://dx.doi.org/10.1016/j.jamda.2021.01.066

Ejemplares similares

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity
por: Han, Junyan, et al.
Publicado: (2021)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study
por: Zamani, Mohammad, et al.
Publicado: (2022)

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
por: Capetti, Amedeo F., et al.
Publicado: (2021)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

SARS-COV-2 IgG antibody response in pregnant women at delivery
por: Tsatsaris, Vassilis, et al.
Publicado: (2021)

Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
por: Yousefi, Zahra, et al.
Publicado: (2022)

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China
por: Ma, Hongwen, et al.
Publicado: (2021)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Role of specific IgE, IgG and IgG4 antibodies to corn dust in exposed workers
por: Park, Hae-Sim, et al.
Publicado: (1998)

Clinical performance of different SARS‐CoV‐2 IgG antibody tests
por: Kohmer, Niko, et al.
Publicado: (2020)

SARS-CoV-2 IgG antibody responses in New York City
por: Reifer, Josh, et al.
Publicado: (2020)

Detection of SARS-CoV-2 IgG antibodies in dried blood spots
por: Turgeon, Coleman T., et al.
Publicado: (2021)

Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers
por: Varona, Jose F., et al.
Publicado: (2022)

A Prospective Study on Rapidly Declining SARS‐CoV‐2 IgG Antibodies Within One to Three Months of Testing IgG Positive: Can It Lead to Potential Reinfections?
por: Nag, Deb Sanjay, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)

Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA
por: Hu, Xiumei, et al.
Publicado: (2020)

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease
por: Kiyama, Kazuhiro, et al.
Publicado: (2015)

The role of IgG Fc receptors in antibody-dependent enhancement
por: Bournazos, Stylianos, et al.
Publicado: (2020)

Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population
por: Mubarak, Ayman, et al.
Publicado: (2022)

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
por: Wan, Jinkai, et al.
Publicado: (2020)

Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2
por: Denning, David W., et al.
Publicado: (2020)

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)

Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees
por: Madsen, Troy, et al.
Publicado: (2020)

Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays
por: Tanis, Jorg, et al.
Publicado: (2021)

Highly active engineered IgG3 antibodies against SARS-CoV-2
por: Kallolimath, Somanath, et al.
Publicado: (2021)

Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022)

SARS-CoV2 IgG antibody: Seroprevalence among health care workers
por: Prakash, Om, et al.
Publicado: (2021)

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany
por: Mksoud, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1lkmrsu7phjua84rqs7hakuflo